Home › Funds › ACT Capital Partners, L.P. › CRVS
ACT Capital Partners, L.P. position in CRVS
CORVUS PHARMACEUTICALS INC · Health Care
ACT Capital Partners, L.P. reported holding 27,000 shares of CRVS (CORVUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$311K, representing 0.21% of its reported portfolio and ranking #41 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s CRVS position evolved
ACT Capital Partners, L.P. first disclosed a stake in CRVS in Q3 2026 at 27,000 shares (US$311K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 27.00K | $311.04K | New |
About CRVS and 13F data
CRVS (CORVUS PHARMACEUTICALS INC) is a Health Care company. 73 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), Vivo Capital, LLC (US$41.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRVS
- ORBIMED ADVISORS LLC 7.17M sh · $107.05M · Q2 2026
- ADAMS STREET PARTNERS LLC 3.28M sh · $48.94M · Q2 2026
- Vivo Capital, LLC 2.81M sh · $41.92M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.67M sh · $39.85M · Q2 2026
- Deep Track Capital, LP 2.49M sh · $37.23M · Q2 2026
- BRAIDWELL LP 2.13M sh · $31.77M · Q2 2026
- Foresite Capital Management VI LLC 1.83M sh · $27.36M · Q2 2026
- Boxer Capital Management, LLC 1.10M sh · $16.43M · Q2 2026
- Catalio Capital Management, LP 1.08M sh · $16.15M · Q2 2026
- Eversept Partners, LP 747.99K sh · $11.18M · Q2 2026
- DCF Advisers, LLC 637.50K sh · $9.52M · Q2 2026
- Blue Owl Capital Holdings LP 608.60K sh · $9.09M · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held CRVS?
ACT Capital Partners, L.P. has disclosed CRVS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in CRVS?
As of Q3 2026, ACT Capital Partners, L.P. holds 27.00K shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $311.04K, representing 0.21% of its reported portfolio and ranking #41.
Has ACT Capital Partners, L.P. been buying or selling CRVS?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in CRVS.
Which other funds hold CRVS?
Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Vivo Capital, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.